Elucidating Potential Virulence Factors in Fusobacterium Nucleatum by Kyla L.S Cochrane

Total Page:16

File Type:pdf, Size:1020Kb

Elucidating Potential Virulence Factors in Fusobacterium Nucleatum by Kyla L.S Cochrane Elucidating potential virulence factors in Fusobacterium nucleatum by Kyla L.S Cochrane A Thesis presented to The University of Guelph In partial fulfilment of requirements for the degree of Doctor of Philosophy in Molecular and Cellular Biology Guelph, Ontario, Canada © Kyla L.S. Cochrane, February, 2016 ABSTRACT ELUCIDATING POTENTIAL VIRULENCE FACTORS IN FUSOBACTERIUM NUCLTEAUM Kyla L.S. Cochrane Advisor: University of Guelph, 2016 Dr. Emma Allen-Vercoe Fusobacterium nucleatum (Fn) is a strictly anaerobic, Gram negative bacterial species that has been implicated in multiple clinical pathologies including periodontal disease, inflammatory bowel disease and colorectal cancer (CRC). The species is unusual in its phenotypic and genotypic heterogeneity, with some strains demonstrating a more virulent phenotype than others; however, the genetic basis for these differences and the association of any particular subspecies of Fn with disease has not yet been proven. With the recent confirmation of the Fusobacterium sequence enrichment in colorectal carcinomas, the characterization of cultured Fn isolates from CRC biopsies was warranted. Fn strains were isolated from human intestinal mucosal biopsies and were phenotypically and genetically analyzed. The invasive, inflammatory potential of Fn in vitro was also assessed. There was extensive variability between the phenotypic, invasive and inflammatory potentials of 8 different CRC-derived Fn strains. Further genetic characterization showed the prevalence of a class of genes of unknown function containing MORN2-domains that were expanded in Fusobacterium spp. known to be highly invasive. Proteins containing MORN2-domains are predicted to be surface-associated and as such may play a role in enabling host cell adherence and invasion by fusobacterial species. In addition, the presence of bacteriophages in Fn strains ii were also predicted to explain the genomic heterogeneity between Fn strains especially in relation to adherence and invasion. These predictions prompted the exploration of the Fn transcriptome for the purpose of determining the proteins that govern adherence and subsequent invasion of the bacteria into host cells. Going forward, RNA-seq will be used as a tool to help unravel the mechanisms of Fusobacterium pathogenesis. Continuing research in this area will enable the development of diagnostic and therapeutic strategies for the detection and treatment of Fusobacterium-associated diseases. iii Acknowledgments Firstly, I would like to express my sincere gratitude to my advisor Dr. Emma Allen- Vercoe for not only convincing me to return to the research world but also for her continuous support, patience, motivation and immense knowledge. Most of all, I want to thank her for having the faith in me that was necessary to handle this particular project. It was not always easy but her guidance and unwavering support allowed to me to succeed. Besides my advisor, I would like to thank the rest of my advisory committee: Dr. Nina Jones, Dr. Lucy Mutharia and Dr. Katrina Gee for their insightful comments, encouragement and also for their hard questions, which incented me to widen my research from various perspectives. Additional thanks go to Dr. Abigail Mason McGuire, Dr. Ashlee Earl, Dr. Reggie Lo and Dr. Robert Holt, without their bacterial, genomic and technical expertise I would have been lost. I would also like to acknowledge the government of Ontario for providing financial support throughout my graduate career in the form of scholarships, fellowships and bursaries. Additionally, I would like to recognize the Crohn's and Colitis Canada Foundation and the Canadian Cancer Society Research Institute for providing funding to the Allen-Vercoe lab. Special thanks go out to the members of the Allen-Vercoe lab, past and present, for all of your help in the lab, coffee breaks to vent and shoulders to cry or laugh hysterically on whenever it was a bad science day. In particular I would like to thank the friends who became family: you know who you are. Completing this work would have been all the more difficult were it not for the support provided by my wonderful family, my closest friends, and of course, my best friend and partner, Michael Beswick. It is always impossible to personally thank everyone who has facilitated successful completion of a project. To those of you who I did not specifically name, I give my thanks for moving me towards my goal. I will forever be indebted to you all. iv Author’s Declaration of Works Performed I declare that this dissertation is my own account, based upon work actually carried out by me and that all sources of material, not resulting from my own investigation, including observational information, have been clearly indicated in their representative sections. For the work reported in Section 2.1.1 B, isolation of bacterial strains from colorectal cancer biopsy samples from Cohort One were processed by Dr. Emma Allen-Vercoe and Dr. Jaclyn Strauss. Additional help from both Michelle Daigneault and Dr. Emma Allen-Vercoe was provided occasionally during the isolation of bacterial strains from Cohort Two and Three as well. Sequencing analysis of all bacterial strains isolated from the colorectal cancer biopsies was performed by Sindy Babinsky at the BC Cancer Agency. In Section 2.3.1 A, the Pseudomonas MORN2 recombinant protein was cloned and purified by Dr. Bryan Berger at Lehigh University in Bethlehem, Pennsylvania. Whole genome sequencing and full annotation of the two Fn 7-1 bacteriophage, from Section 2.4.1 C, were performed by Dr. Abigail Manson McGuire and colleagues at the Broad Institute of MIT in Cambridge, Massachusetts. v Table of Contents ABSTRACT .................................................................................................................................... ii Acknowledgments.......................................................................................................................... iv Author’s Declaration of Works Performed ..................................................................................... v List of Figures ................................................................................................................................ ix List of Tables ................................................................................................................................. xi List of Abbreviations .................................................................................................................... xii Chapter 1. Literature Review and Research Objectives ................................................................. 1 1.1 The Gut Microbiota ........................................................................................................... 1 1.2 Commensals, Health and Immunity .................................................................................. 2 1.3 Inflammatory Diseases in the Gut ..................................................................................... 3 1.4 Inflammatory Bowel Disease and the associated risk of Colorectal Cancer ..................... 6 1.5 Fusobacterium nucleatum ................................................................................................. 7 1.6 Fusobacterium nucleatum and Virulence Factors ............................................................. 9 1.7 Fusobacterium nucleatum and Inflammatory Bowel Disease ......................................... 16 1.8 Fusobacterium nucleatum and Colorectal Cancer ........................................................... 18 1.9 Conclusion ....................................................................................................................... 21 1.10 Research Objectives ...................................................................................................... 22 Chapter 2. Materials and Methods ................................................................................................ 23 2.1 Isolation of bacterial species from colorectal cancer biopsies and characterization of isolated Fusobacterium nucleatum (Fn) species. ...................................................................... 23 2.1.1 Bacterial Strains ............................................................................................................ 23 2.1.2 Identification of CRC-derived strains and the characterization of Fn strains .............. 40 2.2 Fn interactions with human colonic epithelial cells ............................................................ 51 2.2.1 Assessing the ability of CRC-derived Fn isolates to invade human epithelial cells in vitro ........................................................................................................................................ 51 2.2.2 Host Immune Response to Fn and CRC-derived Strains ............................................. 63 2.2.3 Assessing the effects of human cytokines on Fn invasion in vitro .............................. 68 2.3 Determining the role of MORN2 domain-associated proteins in Fusobacterium adhesion/invasion ...................................................................................................................... 71 2.3.1 Characterization of MORN2 domains in adhesion and invasion of Fn strains ............ 71 vi 2.4 Determining the presence and role of bacteriophage in invasive Fn strains ....................... 74 2.4.1 Induction and characterization of the invasive Fn subspecies animalis 7-1 bacteriophage ɸFunu1 and ɸFunu2 ......................................................................................
Recommended publications
  • Genomic and Evolutionary Insights
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Apollo GBE Preterm Infant-Associated Clostridium tertium, Clostridium cadaveris,andClostridium paraputrificum Strains: Genomic and Evolutionary Insights Raymond Kiu1,2, Shabhonam Caim1, Cristina Alcon-Giner1, Gusztav Belteki3,PaulClarke4, Derek Pickard5, Gordon Dougan5,andLindsayJ.Hall1,* 1The Gut Health and Food Safety Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, United Kingdom 2Norwich Medical School, Norwich Research Park, University of East Anglia, Norwich, United Kingdom 3Neonatal Intensive Care Unit, The Rosie Hospital, Cambridge University Hospitals NHS Foundation Trust, United Kingdom 4Neonatal Intensive Care Unit, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom 5Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom *Corresponding author: E-mail: [email protected]. Accepted: September 28, 2017 Data deposition: This project has been deposited at European Nucleotide Archive (EMBL-EBI) under the accession PRJEB22142. Bacterial strain deposition: Newly sequenced strains are deposited at National Collection of Type Cultures (NCTC; a culture depository of Public Health England). Abstract Clostridium species (particularly Clostridium difficile, Clostridium botulinum, Clostridium tetani and Clostridium perfringens)are associated with a range of human and animal diseases. Several other species including Clostridium tertium, Clostridium cadaveris, and Clostridium paraputrificum have also been linked with sporadic human infections, however there is very limited, or in some cases, no genomic information publicly available. Thus, we isolated one C. tertium strain, one C. cadaveris strain and three C. paraputrificum strains from preterm infants residing within neonatal intensive care units and performed Whole Genome Sequencing (WGS) using Illumina HiSeq. In this report, we announce the open availability of the draft genomes: C.
    [Show full text]
  • Microbiology of Endodontic Infections
    Scient Open Journal of Dental and Oral Health Access Exploring the World of Science ISSN: 2369-4475 Short Communication Microbiology of Endodontic Infections This article was published in the following Scient Open Access Journal: Journal of Dental and Oral Health Received August 30, 2016; Accepted September 05, 2016; Published September 12, 2016 Harpreet Singh* Abstract Department of Conservative Dentistry & Endodontics, Gian Sagar Dental College, Patiala, Punjab, India Root canal system acts as a ‘privileged sanctuary’ for the growth and survival of endodontic microbiota. This is attributed to the special environment which the microbes get inside the root canals and several other associated factors. Although a variety of microbes have been isolated from the root canal system, bacteria are the most common ones found to be associated with Endodontic infections. This article gives an in-depth view of the microbiology involved in endodontic infections during its different stages. Keywords: Bacteria, Endodontic, Infection, Microbiology Introduction Microorganisms play an unequivocal role in infecting root canal system. Endodontic infections are different from the other oral infections in the fact that they occur in an environment which is closed to begin with since the root canal system is an enclosed one, surrounded by hard tissues all around [1,2]. Most of the diseases of dental pulp and periradicular tissues are associated with microorganisms [3]. Endodontic infections occur and progress when the root canal system gets exposed to the oral environment by one reason or the other and simultaneously when there is fall in the body’s immune when the ingress is from a carious lesion or a traumatic injury to the coronal tooth structure.response [4].However, To begin the with, issue the if notmicrobes taken arecare confined of, ultimately to the leadsintra-radicular to the egress region of pathogensIn total, and bacteria their by-productsdetected from from the the oral apical cavity foramen fall into to 13 the separate periradicular phyla, tissues.
    [Show full text]
  • Developing a Genetic Manipulation System for the Antarctic Archaeon, Halorubrum Lacusprofundi: Investigating Acetamidase Gene Function
    www.nature.com/scientificreports OPEN Developing a genetic manipulation system for the Antarctic archaeon, Halorubrum lacusprofundi: Received: 27 May 2016 Accepted: 16 September 2016 investigating acetamidase gene Published: 06 October 2016 function Y. Liao1, T. J. Williams1, J. C. Walsh2,3, M. Ji1, A. Poljak4, P. M. G. Curmi2, I. G. Duggin3 & R. Cavicchioli1 No systems have been reported for genetic manipulation of cold-adapted Archaea. Halorubrum lacusprofundi is an important member of Deep Lake, Antarctica (~10% of the population), and is amendable to laboratory cultivation. Here we report the development of a shuttle-vector and targeted gene-knockout system for this species. To investigate the function of acetamidase/formamidase genes, a class of genes not experimentally studied in Archaea, the acetamidase gene, amd3, was disrupted. The wild-type grew on acetamide as a sole source of carbon and nitrogen, but the mutant did not. Acetamidase/formamidase genes were found to form three distinct clades within a broad distribution of Archaea and Bacteria. Genes were present within lineages characterized by aerobic growth in low nutrient environments (e.g. haloarchaea, Starkeya) but absent from lineages containing anaerobes or facultative anaerobes (e.g. methanogens, Epsilonproteobacteria) or parasites of animals and plants (e.g. Chlamydiae). While acetamide is not a well characterized natural substrate, the build-up of plastic pollutants in the environment provides a potential source of introduced acetamide. In view of the extent and pattern of distribution of acetamidase/formamidase sequences within Archaea and Bacteria, we speculate that acetamide from plastics may promote the selection of amd/fmd genes in an increasing number of environmental microorganisms.
    [Show full text]
  • Introduction to Bacteriology and Bacterial Structure/Function
    INTRODUCTION TO BACTERIOLOGY AND BACTERIAL STRUCTURE/FUNCTION LEARNING OBJECTIVES To describe historical landmarks of medical microbiology To describe Koch’s Postulates To describe the characteristic structures and chemical nature of cellular constituents that distinguish eukaryotic and prokaryotic cells To describe chemical, structural, and functional components of the bacterial cytoplasmic and outer membranes, cell wall and surface appendages To name the general structures, and polymers that make up bacterial cell walls To explain the differences between gram negative and gram positive cells To describe the chemical composition, function and serological classification as H antigen of bacterial flagella and how they differ from flagella of eucaryotic cells To describe the chemical composition and function of pili To explain the unique chemical composition of bacterial spores To list medically relevant bacteria that form spores To explain the function of spores in terms of chemical and heat resistance To describe characteristics of different types of membrane transport To describe the exact cellular location and serological classification as O antigen of Lipopolysaccharide (LPS) To explain how the structure of LPS confers antigenic specificity and toxicity To describe the exact cellular location of Lipid A To explain the term endotoxin in terms of its chemical composition and location in bacterial cells INTRODUCTION TO BACTERIOLOGY 1. Two main threads in the history of bacteriology: 1) the natural history of bacteria and 2) the contagious nature of infectious diseases, were united in the latter half of the 19th century. During that period many of the bacteria that cause human disease were identified and characterized. 2. Individual bacteria were first observed microscopically by Antony van Leeuwenhoek at the end of the 17th century.
    [Show full text]
  • Product Sheet Info
    Product Information Sheet for HM-13 Oribacterium sinus, Strain F0268 2% yeast extract (ATCC medium 1834) or equivalent Wilkins-Chalgren anaerobe agar with 5% defibrinated sheep blood or equivalent Catalog No. HM-13 Incubation: Temperature: 37°C For research use only. Not for human use. Atmosphere: Anaerobic (80% N2:10% CO2:10% H2) Propagation: Contributor: 1. Keep vial frozen until ready for use, then thaw. Jacques Izard, Assistant Member of the Staff, Department of 2. Transfer the entire thawed aliquot into a single tube of Molecular Genetics, The Forsyth Institute, Boston, broth. Massachusetts 3. Use several drops of the suspension to inoculate an agar slant and/or plate. Manufacturer: 4. Incubate the tube, slant and/or plate at 37°C for 48 to BEI Resources 72 hours. Product Description: Citation: Bacteria Classification: Lachnospiraceae, Oribacterium Acknowledgment for publications should read “The following Species: Oribacterium sinus reagent was obtained through BEI Resources, NIAID, NIH as Strain: F0268 part of the Human Microbiome Project: Oribacterium sinus, Original Source: Oribacterium sinus (O. sinus), strain F0268 Strain F0268, HM-13.” was isolated in June 1980 from the subgingival plaque of a 27-year-old white female patient with severe periodontitis in Biosafety Level: 1 the United States.1,2 Appropriate safety procedures should always be used with Comments: O. sinus, strain F0268 (HMP ID 6123) is a this material. Laboratory safety is discussed in the following reference genome for The Human Microbiome Project publication: U.S. Department of Health and Human Services, (HMP). HMP is an initiative to identify and characterize Public Health Service, Centers for Disease Control and human microbial flora.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites
    DMD Fast Forward. Published on December 31, 2018 as DOI: 10.1124/dmd.118.084772 This article has not been copyedited and formatted. The final version may differ from this version. DMD #84772 Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites Yukuang Guo1,5, Camila Manoel Crnkovic1, Kyoung-Jae Won2, Xiaotong Yang4, John Richard Lee3, Jimmy Orjala1,5, Hyunwoo Lee1,5, and Hyunyoung Jeong2,4,5 1, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago Downloaded from 2, Department of Pharmacy Practice, University of Illinois at Chicago 3, Division of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine 4, Department of Biopharmaceutical Sciences, University of Illinois at Chicago dmd.aspetjournals.org 5, Center for Biomolecular Sciences at ASPET Journals on September 26, 2021 1 DMD Fast Forward. Published on December 31, 2018 as DOI: 10.1124/dmd.118.084772 This article has not been copyedited and formatted. The final version may differ from this version. DMD #84772 Running title: Tacrolimus metabolism by gut bacteria Correspondence and requests for materials should be addressed to J.O. (for tacrolimus metabolite M1), H.L. (for bacteria), and H.J. (for the rest). Jimmy Orjala, [email protected] Hyunwoo Lee, [email protected] Hyunyoung Jeong, [email protected] College of Pharmacy, University of Illinois at Chicago Downloaded from 900 South Ashland Ave, Chicago, IL 60607 # text pages: 26 dmd.aspetjournals.org # table: 3 # figure: 6 # references: 32 at ASPET
    [Show full text]
  • Targeting the Gut Microbiome in Allogeneic Hematopoietic Stem Cell Transplantation
    medRxiv preprint doi: https://doi.org/10.1101/2020.04.08.20058198; this version posted June 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Targeting the gut microbiome in allogeneic hematopoietic stem cell transplantation Marcel A. de Leeuw & Manuel X. Duval, GeneCreek List of Figures Contents 1 GM composition evolution across allo-HSCT . 2 I 2 Baseline GM composition and conditioning level . 3 NTRODUCTION 1 3 Top 10 variable importances estimated by the ran- dom survival forest models .............. 3 MATERIALS & METHODS 2 4 Biological safety level and aGvHD at onset . 3 DATA ANALYSIS .................. 2 5 Relative importance of regressors explaining the RESULTS 2 aGvHD status ...................... 3 OVERALL GM COMPOSITION EVOLUTION ACROSS 6 Co-exclusion by and co-occurrence with QPS species 4 ALLO-HSCT ................. 2 List of Tables CORRELATION BETWEEN CONDITIONING AND THE GM 2 BASELINE GM COMPOSITION AND SURVIVAL . 3 1 Prospective data sets used in the study . 1 AGVHD CASES, CONTROLS AND GM COMPOSITION 3 IMMUNO-MODULATING METABOLITES . 4 IN SILICO SCREENING OF THE ALLO-HSCT GM . 4 DISCUSSION 4 CONCLUSIONS 6 SUMMARY 6 DECLARATIONS 6 BIBLIOGRAPHY 7 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. Revised manuscript medRxiv preprint doi: https://doi.org/10.1101/2020.04.08.20058198; this version posted June 9, 2020.
    [Show full text]
  • Quantitative and Qualitative Analysis of Microorganisms in Root‑Filled Teeth with Persistent Infection: Monitoring of the Endodontic Retreatment
    Published online: 2019-09-26 Original Article Quantitative and qualitative analysis of microorganisms in root‑filled teeth with persistent infection: Monitoring of the endodontic retreatment Marcos S. Endo1, Caio C. R. Ferraz1, Alexandre A. Zaia1, Jose F. A. Almeida1, Brenda P. F. A. Gomes1 1Department of Restorative Dentistry, Endodontics Correspondence: Dr. Brenda PFA Gomes Division, Piracicaba Dental School – State University Email: [email protected] of Campinas – UNICAMP, Piracicaba, SP, Brazil ABSTRACT Objective: The aim of this study was to investigate in vivo microorganisms detected in root‑filled teeth with post‑treatment apical periodontitis and quantify colony‑forming units (CFU) during endodontic retreatment. Materials and Methods: Fifteen root‑filled teeth had their previous gutta‑percha removed and were randomly instrumented before being divided into three groups and medicated with either [Ca (OH) 2 + 2% CHX gel], [Ca (OH) 2 + 0.9% NaCl] or 2% CHX gel. Samples were taken after removal of gutta‑percha (S1), after chemomechanical preparation using 2% CHX gel (S2), and after inter‑appointment dressing (S3) for 7 or 14 days later. Cultivable bacteria recovered from infected root canals at the three stages were counted and identified by means of culture and PCR assay (16S rDNA). Quantitative data were statistically analyzed by using Mann‑Whitney test in which pairs of groups were compared (P < 0.05). Results: CFU counts decreased significantly from S1 to S2 (P < 0.05). No significant difference was found between S2 and S3 (P = 0.3093) for all three experimental groups. Chemomechanical preparation and intra‑canal dressing promoted significant median reductions of 99.61% and 99.57%, respectively, in the number of bacteria compared to S1 samples.
    [Show full text]
  • Integrating Taxonomic, Functional, and Strain-Level Profiling of Diverse
    TOOLS AND RESOURCES Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 Francesco Beghini1†, Lauren J McIver2†, Aitor Blanco-Mı´guez1, Leonard Dubois1, Francesco Asnicar1, Sagun Maharjan2,3, Ana Mailyan2,3, Paolo Manghi1, Matthias Scholz4, Andrew Maltez Thomas1, Mireia Valles-Colomer1, George Weingart2,3, Yancong Zhang2,3, Moreno Zolfo1, Curtis Huttenhower2,3*, Eric A Franzosa2,3*, Nicola Segata1,5* 1Department CIBIO, University of Trento, Trento, Italy; 2Harvard T.H. Chan School of Public Health, Boston, United States; 3The Broad Institute of MIT and Harvard, Cambridge, United States; 4Department of Food Quality and Nutrition, Research and Innovation Center, Edmund Mach Foundation, San Michele all’Adige, Italy; 5IEO, European Institute of Oncology IRCCS, Milan, Italy Abstract Culture-independent analyses of microbial communities have progressed dramatically in the last decade, particularly due to advances in methods for biological profiling via shotgun metagenomics. Opportunities for improvement continue to accelerate, with greater access to multi-omics, microbial reference genomes, and strain-level diversity. To leverage these, we present bioBakery 3, a set of integrated, improved methods for taxonomic, strain-level, functional, and *For correspondence: phylogenetic profiling of metagenomes newly developed to build on the largest set of reference [email protected] (CH); sequences now available. Compared to current alternatives, MetaPhlAn 3 increases the accuracy of [email protected] (EAF); taxonomic profiling, and HUMAnN 3 improves that of functional potential and activity. These [email protected] (NS) methods detected novel disease-microbiome links in applications to CRC (1262 metagenomes) and †These authors contributed IBD (1635 metagenomes and 817 metatranscriptomes).
    [Show full text]
  • Protein Secretion Systems in Fusobacterium Nucleatum
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1713 (2005) 92 – 112 http://www.elsevier.com/locate/bba Protein secretion systems in Fusobacterium nucleatum: Genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis Mickae¨l Desvauxa,b, Arshad Khana, Scott A. Beatsona, Anthony Scott-Tuckera, Ian R. Hendersona,* aThe Institute for Biomedical Research (IBR), The University of Birmingham-The Medical School, Division of Immunity and Infection, Bacterial Pathogenesis and Genomics Unit, Edgbaston, Birmingham B15 2TT, UK bInstitut National de la Recherche Agronomique (INRA), Centre de Recherches de Clermont-Ferrand-Theix, Unite´ de Recherche 370, Equipe Microbiologie, F-63122 Saint-Gene`s Champanelle, France Received 23 February 2005; received in revised form 11 April 2005; accepted 2 May 2005 Available online 8 June 2005 Abstract Recent genomic analyses of the two sequenced strains F. nucleatum subsp. nucleatum ATCC 25586 and F. nucleatum subsp. vincentii ATCC 49256 suggested that the major protein secretion systems were absent. However, such a paucity of protein secretion systems is incongruous with F. nucleatum pathogenesis. Moreover, the presence of one or more such systems has been described for every other Gram- negative organism sequenced to date. In this investigation, the question of protein secretion in F. nucleatum was revisited. In the current study, the absence in F. nucleatum of a twin-arginine translocation system (TC #2.A.64.), a Type III secretion system (TC #3.A.6.), a Type IV secretion system (TC #3.A.7.) and a chaperone/usher pathway (TC #1.B.11.) was confirmed.
    [Show full text]
  • Bacterial Diversity and Functional Analysis of Severe Early Childhood
    www.nature.com/scientificreports OPEN Bacterial diversity and functional analysis of severe early childhood caries and recurrence in India Balakrishnan Kalpana1,3, Puniethaa Prabhu3, Ashaq Hussain Bhat3, Arunsaikiran Senthilkumar3, Raj Pranap Arun1, Sharath Asokan4, Sachin S. Gunthe2 & Rama S. Verma1,5* Dental caries is the most prevalent oral disease afecting nearly 70% of children in India and elsewhere. Micro-ecological niche based acidifcation due to dysbiosis in oral microbiome are crucial for caries onset and progression. Here we report the tooth bacteriome diversity compared in Indian children with caries free (CF), severe early childhood caries (SC) and recurrent caries (RC). High quality V3–V4 amplicon sequencing revealed that SC exhibited high bacterial diversity with unique combination and interrelationship. Gracillibacteria_GN02 and TM7 were unique in CF and SC respectively, while Bacteroidetes, Fusobacteria were signifcantly high in RC. Interestingly, we found Streptococcus oralis subsp. tigurinus clade 071 in all groups with signifcant abundance in SC and RC. Positive correlation between low and high abundant bacteria as well as with TCS, PTS and ABC transporters were seen from co-occurrence network analysis. This could lead to persistence of SC niche resulting in RC. Comparative in vitro assessment of bioflm formation showed that the standard culture of S. oralis and its phylogenetically similar clinical isolates showed profound bioflm formation and augmented the growth and enhanced bioflm formation in S. mutans in both dual and multispecies cultures. Interaction among more than 700 species of microbiota under diferent micro-ecological niches of the human oral cavity1,2 acts as a primary defense against various pathogens. Tis has been observed to play a signifcant role in child’s oral and general health.
    [Show full text]